We investigated the quantitative and morphofunctional alterations of neuron-astrocyte-microglia triads in CA3 hippocampus, in comparison to CA1, after 2 Vessel Occlusion (2VO) and the protective effect of dipyridamole. We evaluated 3 experimental groups: sham-operated rats (sham, n = 15), 2VO-operated rats treated with vehicle (2VO-vehicle, n = 15), and 2VO-operated rats treated with dipyridamole from day 0 to day 7 (2VO-dipyridamole, n = 15), 90 days after 2VO. We analyzed Stratum Pyramidalis (SP), Stratum Lucidum (SL) and Stratum Radiatum (SR) of CA3. 1) ectopic neurons increased in SL and SR of 2VO-vehicle, and 2VO-dipyridamole rats; 2) apoptotic neurons increased in SP of 2VO-vehicle rats and dipyridamole reverted this effect; 3) astrocytes increased in SP, SL and SR of 2VO-vehicle and 2VO-dipyridamole rats; 4) TNF-α expression increased in astrocytes, blocked by dipyridamole, and in dendrites in SR of 2VO-vehicle rats; 5) total microglia increased in SL and SR of 2VO-vehicle and 2VO-dipyridamole rats; 6) triads increased in SR of 2VO-vehicle rats and dipyridamole reverted this effect. Microglia cooperated with astrocytes to phagocytosis of apoptotic neurons and debris, and engulfed ectopic non-fragmented neurons in SL of 2VO-vehicle and 2VO-dipyridamole rats, through a new mechanism called phagoptosis. CA3 showed a better adaptive capacity than CA1 to the ischemic insult, possibly due to the different behaviour of astrocytes and microglial cells. Dipyridamole had neuroprotective effects.
Introduction
The hippocampus is the most susceptible region of the brain to deprivation of oxygen and glucose that takes place during ischemia, with the highest vulnerability in CA1 and the lower sensitivity in CA3 (Kirino 2000) . The ischemia-induced cellular damage can be acute, as it occurs during stroke, or chronic, as it occurs in human aging. Chronic ischemia is a progressive neurodegenerative process caused by cerebral hypoperfusion that may manifest with cognitive impairment (Sarti et al. 2002b; Melani et al. 2010; Schmidt-Kastner et al. 2005; Lana et al. 2013) . Indeed, chronic hypoperfusion of the brain, secondary to vascular pathology, is a prominent risk factor for neurodegenerative diseases (Naritomi 1991) such as vascular dementia (Chmayssani et al. 2007 ). In aging humans, cerebrovascular stenosis caused by arteriosclerosis decreases brain blood flow with consequent cerebral hypoperfusion. Resolution of cerebrovascular stenosis has been reported to improve mental decline (Nencini et al. 1993; Tatemichi et al. 1995; Tsuda et al. 1994; Hirono et al. 1993) .
The permanent, bilateral occlusion of the common carotid arteries of rats (two-vessel occlusion, 2VO) is a procedure that mimics age-related cerebrovascular stenosis and is widely utilized to investigate the mechanisms of chronic cerebral hypoperfusion and consequent neurodegenerative processes (Farkas et al. 2007; Sarti et al. 2002a Sarti et al. , 2002b Lana et al. 2014 ). The 2VO model has revealed that, the CA1 region of the hippocampus is particularly vulnerable not only to acute ischemia but also to hypoperfusion given by the 2VO, with consequent failure of neuronal signaling, and to learning and memory disturbances (Farkas et al. 2006; Melani et al. 2010; Ohtaki et al. 2006; Schmidt-Kastner et al. 2001; Shibata et al. 2004) . A growing body of evidence indicates that distinct mechanisms mediate the differential vulnerability of CA1 and CA3 neurons to the ischemia induced excitotoxicity and delayed cell death. It is known for instance that there exist differential responses of glutamate NMDA and AMPA receptor subtypes between CA1 and CA3 neurons after ischemia (Stanika et al. 2010; Gee et al. 2006; Dos-Anjos et al. 2009 ). Nevertheless, the complex cellular mechanisms underlying differential responses of CA1 and CA3 neurons to ischemic insult remain unclear.
Although brain disease is generally attributed solely to malfunction of neurons, recently it is becoming more and more evident that proper interplay between neurons, astrocytes and microglia, forming the so called "triad" (Cerbai et al., 2012) , is fundamental for the physio-pathological organization of the brain (Allen and Barres 2009; Barres 2008) . Impaired or deranged interplay among neurons and glia may shift the balance from normal brain physiology to neurodegeneration (De Keyser et al. 2008; Sofroniew 2009 ). Nevertheless, the precise role of microglia and/or astrocytes in neurodegenerative mechanisms has not yet been clearly defined. How apoptosis causes a neuron to die is still a matter of debate, but it is believed that the main means is through the production from neurons of signals which induce phagocytic cells to eat the neuron (Noda et al. 2011) . Different, and even contrasting aspects have to be considered in physiological and pathological neuronal apoptosis, since it has been demonstrated that signals produced by neurons undergoing physiological apoptosis are different from signals induced during neurodegenerative diseases (Lauber et al. 2004; Takahashi et al. 2005) . It has been shown that microglia and astrocytes can be neuroprotective to a certain extent (Faulkner et al. 2004; Hanisch and Kettenmann 2007; Li et al. 2008; Myer et al. 2006 ), but they can be dangerous for neuronal health (Block et al. 2007) . We have previously demonstrated in rat models of normal brain aging, of brain inflammation and chronic hypoxia, that in CA1 astrocytes and microglia actively collaborate in the clearance of apoptotic neurons and of neuronal debris (Cerbai et al. 2012; Lana et al. 2014 ). More specifically, in the rat model of cerebral hypoperfusion we demonstrated (Lana et al. 2014 ) significant alteration in the interplay between neurons and glia in CA1 of 2VO-vehicle rats. The administration of dipyridamole during the acute phase of brain chronic hypoperfusion, reverting many of the effects observed in 2VO-vehicle rats, may be responsible for the prevention of the progression of the pathophysiological mechanisms after 2VO occlusion.
Based upon these previous results, aim of the present research was to investigate if and how the interaction between glial cells and neurons change during chronic hypoperfusion in the three different subregions of CA3 hippocampus, namely Stratum Pyramidale (SP), Stratum Lucidum (SL) and Stratum Radiatum (SR). We focused on changes in CA3 because it has an important role in memory processing and because it demonstrates milder functional, structural, and morphological alterations during ischemia than CA1. Therefore, a correlation with the modifications previously found in CA1 (Lana et al. 2014 ) will be of particular interest. Furthermore, since few pharmacological therapies able to improve neurodegeneration and memory deficits in patients with chronic cerebrovascular pathologies are so far available, to find targets for new therapeutic strategies it is imperative to understand the pathophysiological mechanisms that link chronic ischemia with neurodegeneration and alterations of brain functions.
Materials and methods

Animals
Male adult Wistar rats (3 months old, Harlan, Milano, Italy) were used. The animals were housed in cages with ad libitum food and water and were maintained on a 12 h light-12 h dark cycle in a temperaturecontrolled room (23 ± 1°C). Experiments were approved by the IACUC of the University of Florence and performed according to the Italian Law on Animal Welfare (DL 116/92, Italian Directive on the protection of animals used for scientific purposes). All efforts were made to minimize animal sufferings and to use only the number of animals necessary to produce reliable scientific data.
Surgery
Bilateral common carotid artery occlusion (two-vessel occlusion, 2VO) was carried out in rats (Sarti et al. 2002a (Sarti et al. , 2002b Farkas et al. 2007) according to the scheme represented in Fig. 1A , according to the method previously published (Lana et al. 2014) . Briefly, rats were anesthetised with halothane and the right common carotid artery was occluded, (day -7, Fig. 1A ), as follows. After exposure, the common carotid artery was exposed and firmly ligated with a silk suture. After one week (day 0, Fig. 1A ), the left common carotid artery was occluded using the same procedure. Diaminocillin (1,200,000 U in 8 ml saline, 1 ml/day i.m.) was administered after each procedure. Sham rats underwent the same surgical procedures, but the arteries were not occluded. Animals were randomly allocated in 3 experimental groups: sham-operated rats (sham, n = 15), 2VO-operated rats treated with vehicle (2VO-vehicle, n = 15), and 2VO-operated rats treated with dipyridamole (2VO-dipyridamole, n = 15) from day 0 to day 7. We did not include the sham-dipyridamole-treated animals group in the project because we wanted to verify the effect of the drug in 2VO treated rats.
Drug administration
Dipyridamole (Persantin, Boehringer Ingelheim, 5 mg/ml) or vehicle were administered into the jugular vein (10 μL/h per 7 days) using a miniosmotic pump (Model 2001, Alzet, Cupertino, CA, USA) according to Lana et al. (2014) . The pumps were implanted subcutaneously in the thoraco-lumbar region immediately after the left common carotid artery occlusion and removed after 7 days (Fig. 1A) . Each animal received about 4 mg/kg/day of dipyridamole which gave an estimated dipyridamole plasma concentration of 2-2.5 μM plasma concentration over the entire week, close to the therapeutic concentration (1.6 μg/ml) reached after extended-release dipyridamole administered to ischemic stroke patients (Serebruany et al. 2009 ).
Fluorescent immunohistochemistry
The following primary antibodies were used: a mouse monoclonal anti-neuronal nuclei (NeuN, 1:200; Millipore, Billerica, MA) for neurons; a rabbit polyclonal anti-glial fibrillary acidic protein (GFAP, 1:1000; DakoCytomation, Glostrup, Denmark) for astrocytes; a rabbit polyclonal anti-IBA1 (1:300, WAKO Pure Chem. Ind, Osaka, Japan) for microglia; a mouse monoclonal anti-Cytochrome C (Cyt C, 1:200, Becton and Dickinson, Franklin Lakes, NJ, USA) as an apoptotic marker; a rabbit polyclonal anti-TNF-α (1:500, ThermoFisher Scientific, Ealtham, MA, USA); a rabbit polyclonal anti-calretinin antibody (1:200, Millipore, Billerica, MA, USA) for CA3 interneurons; a mouse monoclonal anti-neurofilament antibody (1:100, Cell Signaling Technology, Danvers, MA, USA) for dendrites. In triple staining for astrocytes, microglia and neurons, astrocytes were labelled with a mouse monoclonal anti-GFAP antibody conjugated with the fluorochrome AlexaFluor 488 (1:500), in triple staining for neurons, microglia and cytochrome C, neurons were labelled with a mouse monoclonal anti-NeuN antibody conjugated with the fluorochrome AlexaFluor 488 (1:100), both from Millipore (Billerica, MA, USA). The following fluorescent secondary antibodies were used: AlexaFluor 488 donkey anti-rabbit (1:400), AlexaFluor 594 goat anti-mouse (1:400), AlexaFluor 555 donkey anti-mouse (1:400), Alexa Fluor 635 goat anti-rabbit (1:400) (all from Life Technologies, Carlsbad, CA, USA). Colocalization of different antigens was performed using combinations of different primary and secondary antibodies, using double or triple labeling confocal microscopy. Nuclei were stained using DAPI (Vectashield hard set mounting medium containing DAPI, Vector Laboratories).
Ninety days after surgery, anesthetized rats were perfused transcardially with 500 ml of ice-cold paraformaldehyde (4% in phosphate-buffered saline, PBS, pH 7.4). After overnight postfixation and cryoprotection (18% sucrose/PBS) 40 μm thick coronal sections were cut with a cryostat, and stored at − 20°C in anti-freeze solution until immunohistochemistry.
Immunostaining was performed on coronal sections with the freefloating method (Giovannini 2002; Lana et al. 2014) .
Day 1. Free-floating sections were placed in wells, blocked for 60 min with Blocking Buffer (BB) containing 10% Normal Goat Serum-10% Normal Horse Serum in PBS-TX and were incubated overnight at 4°C with a combination of two different primary antibodies dissolved in BB (depending on the antigens to be visualized).
Day 2. For double immunostaining, sections were incubated for 2 h at room temperature in the dark with the appropriate secondary antibody (see above).
For triple immunostaining, sections were incubated for 2 h at room temperature in the dark with AlexaFluor 555 donkey anti mouse IgG (1:400) secondary antibody and then for 2 h at room temperature in the dark with AlexaFluor 555 donkey anti mouse IgG (1:400) plus Alexa Fluor 635 goat anti-rabbit (1:400). Depending on the antigens to be visualized, astrocytes were immunostained using the primary antibody anti-GFAP AlexaFluor 488-conjugated and neurons were immunostained using the primary antibody anti-NeuN AlexaFluor 488-conjugated. Sections were mounted onto gelatin-coated slides using Vectashield hard set mounting medium with DAPI (Vector Laboratories). To verify the specificity of the staining, control immunostaining was performed omitting the primary or secondary antibodies.
Sections were observed under an epifluorescent microscope Olympus BX40 equipped with an Olympus DP 50 digital camera (Olympus, Milan, Italy) or under a LEICA TCS SP5 confocal laser scanning microscope (Leica Microsystems CMS GmbH, Mannheim, Germany). Confocal scans were taken at 0.3 μm z-steps keeping pinhole, contrast and brightness constant. Voxel size was 6.75 × 10 −3 μm 3 . Images were digitally converted to green, red or blue using Image J (National Institute of Health, http://rsb.info.nih.gov/ij), digitally combined to obtain single, double or triple labelled images and then assembled into montages. 3D renderings of the images were obtained using Image J 3D viewer.
Methodological considerations
All confocal qualitative double or triple immunostaining analyses were performed in 2VO-vehicle, 2VO-dipyridamole and sham rats. All analyses were performed in Area CA3 of the hippocampus (Lorente de Nó 1934; Li et al. 1994) , defined Region of Interest (ROI, Fig. 1B ), further subdivided into the subregions Stratum Pyramidale (SP), Stratum Lucidum (SL), and Stratum Radiatum (SR) as shown in Figure 1B1 (Amaral and Lavenex 2007; Lana et al. 2016) . Quantification analyses were performed in SP, SL and SR ( Figure 1B1 ) by two researchers blind to the experimental conditions and results were averaged. Three coronal sections (spaced by 150 μm, starting at about −2.8 mm from bregma) containing the ROI were immunostained. Since differences were never found between the two hippocampi (Sarti et al. 2002b; Lana et al. 2014 ) the regions of interest (ROI) of both CA3 areas, containing SP, SL and SR were used. Areas of SP, SL and SR were measured in mm 2 . Astrocytes, microglia, ectopic neurons, neuronal debris and the neurons-astrocytes-microglia triads in CA3 SL and SR, and apoptotic neurons in CA3 SP were consistently counted in the same area in all sections and were expressed as cells/mm 2 . CA3 pyramidal neurons were quantified counting NeuN positive cells in SP. Neuronal debris, defined as NeuN-positive fragments with dimensions between 2.5 μm and 6.5 μm, were counted in the central z-scans (15 μm total thickness) of confocal microscopy images to make sure that we were not capturing ends of whole cells. The length of principal astrocyte branches was measured using Image J. Two independent experimenters measured 4 principal branches of three astrocytes chosen randomly in the ROIs, and results were averaged. The length of TNF-α positive dendrites (3 dendrites chosen randomly in 4 quadrants of a 20× image taken in CA3 SR) was measured using Image J by two independent experimenters and results were averaged. Since IBA1 labels not only microglia, but also monocytes and macrophages, care was taken to avoid the quantification of IBA1 positive cells located inside blood vessels. A "triad" was defined as a neuron in direct contact with a microglia cell and astrocyte branches deriving from surrounding astrocyte(s) (Cerbai et al. 2012; Lana et al. 2016) . To visualize the "top-down view" and the "bottom-up view" of the triad, the 3D rendering was digitally rotated by 180°. The reciprocal interaction of the three cells in the triad was visualized by stacking few consecutive confocal z-scans acquired in the depth of the neuronal cell body and digitally "sub-slicing" the neuron. The 3D rendering image was obtained using ImageJ 3D viewer. Control immunostaining, to verify the specificity of the antibodies, was performed omitting the primary or secondary antibodies.
Statistical analysis
Statistical comparisons were performed using Graph Pad Prism (Graph Pad Software Inc., La Jolla, CA, USA) by one way ANOVA followed by Newman-Keuls Multiple Comparison Test, two way ANOVA followed by Bonferroni multiple comparison test, or two tailed Student's t-test, as appropriate. Significance was set at P b 0.05.
Results
Using the method of simultaneous triple immunostaining of neurons, astrocytes and microglia astrocytes and microglia were shown to cooperate in the fragmentation of apoptotic neurons and in the clearance of neuronal debris in CA1 hippocampus (Cerbai et al. 2012; Lana et al. 2014) . Using the same method here we further characterized the interplay among neurons and glia in CA3 Str. Pyramidale, Str. Lucidum and Str. Radiatum of the rat after chronic cerebral hypoperfusion.
3.1. Analysis of neurons and neuronal debris in CA3 Stratum Pyramidale, Stratum Lucidum and Stratum Radiatum of sham, 2VO-vehicle, and 2VO-dipyridamole treated rats
In order to evaluate whether chronic ischemia may cause loss of neurons in area CA3, we performed an analysis of neurons immunolabelled with anti-NeuN antibody in SP, SL and SR of CA3 of sham (SHAM), 2VO-vehicle, and 2VO-dipyridamole treated rats ( Fig.  2A-C) .
Our results demonstrated that there was no significant decrease of pyramidal neurons in 2VO-vehicle in comparison to controls (Oneway Anova: F (2,14) = 0.9879, ns, Fig. 2D ). It has been reported that SL of area CA3 is mainly a-neuronal (Amaral and Lavenex 2007) . Nevertheless, immunostaining of neurons using the anti-NeuN antibody revealed the presence of numerous neurons, that we defined "ectopic", scattered throughout the SL of 2VO-vehicle and 2VO-dipyridamole treated rats. Quantitative analysis in Fig. 2F (plain columns) showed that ectopic neurons were significantly more numerous in 2VO-vehicle rats (+78%) and in 2VO-dipyridamole treated rats (+140%) in comparison to sham rats (One-way ANOVA: F (2,13) = 15.14, P b 0.001; NewmanKeuls post-test: *P b 0.05 2VO-vehicle vs sham, ***P b 0.001 2VO-dipyridamole treated rats vs Sham). In SR, ectopic neurons were significantly more neurons in 2VO-vehicle (+103%) and 2VO-dipyridamole treated rats (+ 98%) in comparison to sham rats (One-way ANOVA, F (2,14) = 29.65, P b 0.001, Newman-Keuls post-test, ***P b 0.001 2VO-dipyridamole treated rats vs Sham, 2VO-vehicle vs Sham). Both in SL and SR we found no significant differences in the number of ectopic neurons between 2VO-vehicle and 2VO-dipyridamole treated rats. It has been described that interneurons in the CA3 SL are calretinin-positive and are known to be sensitive to ischemia (Freund and Maglóczky 1993; Hsu and Buzsáki 1993) . We thus performed calretinin immunostaining of CA3 interneurons (Molgaard et al. 2014) . The anti-calretinin antibody revealed the presence of many interneurons, mainly located in SL CA3, as shown in Fig. 2 E-E3. Quantitative analysis in Fig. 2F (hatched columns) showed that the density of calretinin-positive interneurons was not different in 2VO-vehicle rats or in 2VO-dipyridamole treated rats in comparison to sham rats either in SL or SR. On the other hand, statistical analysis showed that calretinin positive interneurons were significantly less numerous than ectopic neurons in SL of 2VO-vehicle rats or in 2VO-dipyridamole treated rats and in SR of sham and 2VO-vehicle rats or in 2VO-dipyridamole treated rats ( # P b 0.05 and ## P b 0.01 vs ectopic neurons, two-tailed Student's t-test, Fig. 2F ). These latter results indicated that the increased ectopic neurons in 2VO-vehicle rats or in 2VO-dipyridamole treated rats were not calretinin positive interneurons. From the graph in Fig. 2F it is also evident that calretinin positive interneurons were significantly more numerous in SL than in SR of all experimental groups.
As already demonstrated (Cerbai et al. 2012; Lana et al. 2014) , astrocytes branches infiltrating the neuronal cell body seem to be fragmenting ectopic neurons to form neuronal debris, thus cooperating with the microglia in phagocytic events (see below). NeuN staining revealed the presence of neuronal debris (Fig. 3A , and see Methodological considerations) scattered throughout the CA3 SL and SR of sham, 2VO-vehicle and 2VO-dipyridamole rats. Fig. 3A shows a magnification of the framed area in Fig. 2B . The dotted circles evidence neuronal debris in comparison to a neuron (open arrow). In the GFAP and NeuN double stained slice shown in Fig. 3B , representing a "sub-slice" obtained stacking 15 consecutive confocal z scans (0.3 μm each, total thickness 4.5 μm) starting at a depth of 3 μm into the slice, a neuronal debris closely apposed to GFAP + -astrocyte branches is clearly visible (dotted circle). In the figures it is also possible to appreciate the size difference between the debris and a healthy neuronal cell body (open arrow). Quantitative analysis showed that neuronal debris were significantly more numerous in CA3 SL of 2VO-vehicle rats (+ 103%) than in sham rats ( Fig. 3C ) and this effect was reverted in 2VO-dipyridamole rats (+ 29%), as shown by statistical analysis (one way ANOVA F (2,11) = 8.654; P = 0.0055; *P b 0.05 vs the two other groups, Newman-Keuls Multiple Comparison Test). Quantitative analysis in SR showed that neuronal debris were significantly more numerous in CA3 SR of 2VO-vehicle rats (+ 82%) than in sham rats and this effect was reverted in 2VO-dipyridamole rats (+33%), as shown by statistical analysis (one way ANOVA F (2,12) = 8.133; P b 0.0059; * P b 0.001 vs the two other groups, Newman-Keuls Multiple Comparison Test) (Fig. 3C ). From the graph in fig. 3C it is also evident that neuronal debris were significantly more numerous in SL than in SR of all experimental groups.
Analysis of apoptotic neurons in CA3 Stratum Pyramidale of sham, 2VO-vehicle, and 2VO-dipyridamole treated rats
It was previously demonstrated, in a similar animal model of chronic hypoperfusion, that CA1 pyramidal neurons undergo apoptotic death between 2 and 25 weeks after the onset of 2VO (Bennett et al. 1998; Lana et al. 2014) . Therefore, in order to verify in our model whether CA3 pyramidal neurons were also undergoing apoptsis, hippocampal sections from sham, 2VO-vehicle, and 2VO-dipyridamole rats were triple immunostained with anti-NeuN for neurons (green), with anti-CytC, a marker for apoptosis (red), and with anti-IBA1 for microglia (blue) (Fig. 4) . CytC can be taken as a marker of apoptosis since it has been demonstrated that, following complete release from the mitochondria at late stages of apoptosis, becomes highly visible in the cytoplasm (Suen et al. 2008) . The presence of a diffuse CytC immunostaining in the cytoplasm is highly visible in some pyramidal neurons in CA3 SP (open arrows in Fig. 4A -C, that show the merged immunostaining of NeuN and CytC). Fig. 4D represents the magnification of the framed area in Fig. 4B showing the diffuse CytC immunostaining in the cytoplasm of two apoptotic neurons. All CytC positive cells in SP were neurons since they were also NeuN positive. CytC positive neurons in SP were counted. Quantitative analysis shown in Fig. 4E demonstrates that CytC positive neurons were significantly more numerous in 2VO-vehicle rats (+ 82%) than in sham rats and dipyridamole significantly reverted this effect (2VO-dipyridamole + 9% vs sham, n.s.) as shown by statistical analysis (One-way ANOVA: F (2,11) = 5.697, *P = 0.02; Newman-Keuls post-test: *P b 0.05 2VO-vehicle vs sham, # P b 0.05 2VO-dipyridamole vs 2VO-vehicle rats). The white arrows in panel 4B show CytC positive ectopic neurons (red). In order to verify whether CytC positive neurons, undergoing apoptosis, were phagocytosed by microglia, sections were triple immunostained with anti-NeuN for neurons (green), anti-CytC (red), and with anti-IBA1 for microglia (blue) (Fig. 4F ). The image 4F shows a "subslice" of a neuron, obtained from 10 consecutive confocal z scans (thickness 3 μm) acquired starting at a depth of 1.8 μm into the neuron, showing the internal part of the cell. The presence of a diffuse CytC immunostaining in the cytoplasm indicates that the cell is undergoing apoptosis. The merge of the three immunostaining shows that the apoptotic CytC positive neuron was in contact with a microglial cell (blue, white arrow). The image is a clear example of a microglial cell projecting its branches to surround and to infiltrate the neuronal cell body. The images in Fig. 4G1 -G3 show immunostaining with anti-NeuN for neurons (green), and with anti-IBA1 for microglia (blue) of CA3 Str. Pyramidale of 2VO-dipyridamole rat. The image is a "sub-slice" obtained from 33 consecutive confocal z scans (thickness 9.9 μm) acquired starting at a depth of 3.0 μm into the neuron indicated by the open arrow (Fig. 4G1) , showing the internal part of the cell. The merge of the two images shows that a microglial cell is in the act of phagocytosing the pyramidal neuron (open arrows, Fig. 4G3 ). The image is again a clear example of a microglial cell projecting its branches to surround and to infiltrate the neuronal cell body. The neuron shows signs of degeneration.
The images in Fig. 4H1-H3 show immunostaining with anti-NeuN for neurons (green), and with anti-IBA1 for microglia (blue) of CA3 Str. Radiatum of 2VO rat. The image is a "sub-slice" obtained from 8 consecutive confocal z scans (thickness 2.4 μm) acquired starting at a depth of 6.0 μm into the neuron indicated by the open arrow, showing the internal part of the cell. The merge of the two images shows that a microglial cell is in the act of phagocytosing the ectopic neuron (open arrows, Fig. 4H3 ). The image is an example of a microglial cell projecting its branches to surround and to infiltrate the neuron which does not appear to have any sign of degeneration.
3.3. Analysis of astrocytes in CA3 Stratum Pyramidale, Stratum Lucidum and Stratum Radiatum of sham, 2VO-vehicle, and 2VO-dipyridamole treated rats Astrocytes were immunolabelled with anti-GFAP antibody (Fig. 5A -C) and quantified in CA3 SP, SL e SR of sham, 2VO-vehicle, and 2VO-dipyridamole rats.
We found a statistically significant increase of astrocytes in SP of 2VO-vehicle (+ 15%) and 2VO-dipyridamole rats (+ 45%) compared to sham rats, as shown in Fig. 5D by statistical analysis (One-way ANOVA: F (2,12) = 17.58, P = 0.0003, Newman-Keuls post-test: ***P b 0.001 2VO-dipyridamole rats vs sham, **P b 0.01 2VO-vehicle vs sham and 2VO-dipyridamole rats). The number of astrocytes did not change significantly in SL of 2VO-vehicle rats (−10%). We found a significant increase of astrocytes in SL of 2VO-dipyridamole rats (+19%) in comparison to sham rats, as shown by statistical analysis (One-way ANOVA: F (2,12) = 9.504, P = 0.0034; Newman-Keuls post-test: *P b 0.05 2VO-dipyridamole vs sham rats). In CA3 SR a significant increase of astrocytes was found both in 2VO-vehicle (+ 18%) and 2VO-dipyridamole rats (+ 18%), as demonstrated by statistical analysis (One-way ANOVA: F (2,12) = 10.18, P = 0.0026; Newman-Keuls posttest: **P b 0.01 2VO-dipyridamole and 2VO-vehicle rats vs sham). demonstrated that no significant differences were found either among the CA3 subregions or among the three experimental groups. (NeuN, green) , CytC (red), and microglia (IBA1, blue) in CA3 SP of 2VO-dipyridamole rats. The panels show a neuron "sub-slice" of 10 consecutive confocal z scans, total thickness 3 μm, acquired starting at 1.8 μm depth into the neuron. The white arrow shows a microglia cell (blue) that approaches an apoptotic neuron, sending its branches to phagocytose it (open arrow). Scale bar: 5 μm. (G1-G3): Representative confocal immunostaining of neurons (NeuN, green) and microglia (IBA1, blue) in CA3 SP of 2VO-dipyridamole rat. The panels show a neuron "sub-slice" of 33 consecutive confocal z scans, total thickness 9.9 μm, acquired starting at 3 μm depth into the neuron. Sub-slice of 33 consecutive confocal z scans of NeuN (green, G1) and IBA1 (blue, G2) immunostaining and the merge of the two previous images (G3). The empty arrow shows a microglia that actively phagocytoses a CA3 pyramidal neuron. Scale bar: 7.5 μm. (H1-H3): sub-slice of 8 consecutive confocal z scans of NeuN (green, H1) and IBA1 (blue, H2) immunostaining and the merge of the two previous images (H3). The open arrow shows a microglia that actively phagocytoses a neuron in CA3 Str. Radiatum. Scale bar: 10 μm.
3.4. TNF-α expression in CA3 Stratum Pyramidale, Stratum Lucidum and Stratum Radiatum of sham, 2VO-vehicle, and 2VO-dipyridamole treated rats
We analyzed whether levels of TNF-α were modified in CA3 of 2VO rats. As shown in Fig. 6A -B, we found a significant increase of TNF-α-positive cells in SR of 2VO-vehicle rats (+ 89% vs sham rats), and dipyridamole completely blocked this effect (−6% vs sham rats, n.s.).
As shown in Fig. 6B statistical analysis performed by one way ANOVA followed by Newman Keuls multiple comparison test demonstrated that this effect was statistically significant (One-way ANOVA: F (2,11) = 4.966, P b 0.05; Newman-Keuls post-test: *P b 0.05 2VO-vehicle vs sham and vs 2VO-dipyridamole). Double labeling immunofluorescent microscopy using antibodies for TNF-α and GFAP demonstrated that TNF-α-positive cells were astrocytes ( Figure 6A1-A3 , magnification of the framed area in Fig. 6A ). Furthermore, in CA3 SL and SR we found an increase of TNF-α expression in neuronal dendrites (Fig. 6A, arrow) . Indeed, double labelled immunofluorescence with antibodies for TNF-α and neurofilament (Fig. 6C-C3 ) demonstrated colocalization of TNF-α in many, but not all, neurofilament-positive dendrites, both in SL and SR of 2VO rats (Fig. 6C1-C3 , magnification of the framed areas in Fig.  6C , arrows). Quantitative analysis of the length of TNF-α positive dendrites in SR (Fig. 6D ) demonstrated a significant increase in 2VO-vehicle rats (+56% vs sham), but dipyridamole only partially reversed this effect (+46% vs sham) (One-way ANOVA: F (2,11) = 6.607, P b 0.05; Newman-Keuls post-test: *P b 0.05 2VO-vehicle and 2VO-dipyridamole vs sham). Fig. 6C1 -C3 clearly show a TNF-α-positive cell (open arrow) negative for neurofilament, possibly representing an astrocyte. We never found any colocalization of TNF-α with microglia markers (data not shown).
Analysis of microglia in CA3 Stratum Pyramidale, Stratum Lucidum and Stratum Radiatum of sham, 2VO-vehicle, and 2VO-dipyridamole treated rats
Total microglia (resting plus activated microglia) was labelled using anti-IBA1 antibody (Fig. 7A-C) in area CA3 SP, SL and SR of sham, 2VO-vehicle and 2VO-dipyridamole rats. IBA1 positive microglia cells were quantified in the ROI of SR (Fig. 7D) . A significant decrease of microglia was found in SP of 2VO-dipyridamole rats (−12%), as demonstrated by statistical analysis (One-way ANOVA: F (2,12) = 1.554; Newman-Keuls post-test: *P b 0.05 2VO-dipyridamole vs sham). A significant increase of microglia was found in SL of 2VO-vehicle (+ 12%) and 2VO-dipyridamole (+ 24%) rats in comparison to sham rats (One-way ANOVA: F (2,12) = 17.56, P = 0.0003; Newman-Keuls post-test: *P b 0.05 2VO-vehicle vs sham, ***P b 0.001 2VO-dipyridamole vs sham, $$P b 0.01 2VO-dipyridamole vs 2VO-vehicle). A significant increase of microglia was also found in SR of 2VO-vehicle (+ 14%) and 2VO-dipyridamole (+ 22%) rats in comparison to sham rats (One-way ANOVA: F (2,12) = 7.865, P b 0.01; Newman-Keuls post-test: **P b 0.01 2VO-dipyridamole vs sham, *P b 0.05 2VO-vehicle vs sham, $P b 0.05 2VO-dipyridamole vs 2VO-vehicle).
We then utilized the OX6 antibody (anti-MHC-II) to visualize activated microglia. Very sparse OX6 positive microglia cells were found in SP, SL and SR of the three experimental groups (see image in Fig.  7E ). Quantitative analysis of OX6-positive activated microglia did not give any significant difference in any area among the three experimental groups (not shown).
Characterization and quantification of neuron-astrocytes-microglia triads in CA3 Stratum Lucidum and Stratum Radiatum of sham, 2VO-vehicle, and 2VO-dipyridamole treated rats
In order to verify the hypothesis that astrocytes and microglia might actively collaborate in the triad formation around apoptotic neurons and neuronal debris in the CA3 region of the hippocampus of 2VO rats as demonstrated in CA1 (Cerbai et al. 2012; Lana et al. 2016) , we studied the interplay among neurons and microglia in CA3 SL and SR of sham, 2VO-vehicle and 2VO-dipyridamole rats using the triple immunostaining of neurons, astrocytes, and microglia.
Neurons, astrocytes, and microglia were triple immunostained in the CA3 of sham, 2VO-vehicle, and 2VO-dipyridamole rats. Triple immunostaining of astrocytes with anti-GFAP antibody (green), neurons with anti-NeuN antibody (red) and microglia with anti-IBA1 antibody (blue) in the CA3 Str. Radiatum of a 2VO-vehicle rat clearly shows the presence of neuron-astrocytes-microglia triads in CA3 SL and SR of all experimental groups (Fig. 8A-C) . Fig. 8B-B1 show an example of neuron-astrocyte-microglia triad in CA3 SR of a 2VO-vehicle rat: the neuron (red) is tightly embraced by astrocyte branches (green)s, the microglial cell (blue) is in a phagocytic state, the three cells are in direct contact each other. The open arrow indicates a neuron fragment engulfed in the cytoplasm of phagocytic microglia. Fig. 8B shows a "top-down view" while 8B1 a "bottom-up view" of the 3D rendering of one triad located in the SR of a 2VO-vehicle rat. It is possible to see that an ectopic neuron is tightly surrounded by astrocyte branches that form a micro scar around it. To complete the triad, a microglia cell (IBA1 positive, blue) is in close contact with the neuronal cell body, possibly phagocytosing the neuron. Indeed, it is clearly visible in panel 8B that portion of the neuronal cytoplasm is engulfed by the microglia cell (arrow). Furthermore, panel 8B2 shows a digital subslice of the neuron-astrocyte-microglia triad shown in panel B (framed area), obtained stacking 3 consecutive z scans (total thickness 0.9 μm) taken at a depth of 7.4 μm inside the neuron. This image clearly shows that astrocyte branches (open arrow), not visible in the top-down and bottom up 3D renderings, located inside the neuronal cell body. These morphological features are consistent with the hypothesis that astrocyte branches are bisecting this ectopic neuron to form neuronal debris. Quantitative analysis of the neuron-astrocytes-microglia triads (as defined in Methodological considerations) was performed in CA3 SL and SR of shams, 2VO-vehicle and 2VO-dipyridamole rats. Results in Fig.  8D show that in SL of 2VO-vehicle and 2VO-dypiridamole rats the number of triads, although increased, was not statistically different from sham rats (One-way ANOVA F (2,10) = 0.947, n.s.). However the number of triads significantly increased in SR of 2VO-vehicle rats (+392%), and dipyridamole partially but significantly prevented this effect (+169%), as shown by statistical analysis (One-way ANOVA F (2,10) = 19.69; P = 0.0003; *** P b 0.001 vs shams; ## P b 0.01 vs 2VO-vehicle; *P b 0.05 vs 2VO-dipyridamole; Newman-Keuls Multiple Comparison Test).
Discussion
In this research we used the model of brain chronic hypoperfusion with the permanent bilateral common carotid artery occlusion or two vessel occlusion (2VO) in the rat (Sarti et al. 2002a (Sarti et al. , 2002b Farkas et al. 2007; Lana et al. 2014 ), a suitable animal species for this purpose since the circle of Willis affords reduced blood flow to the brain (Otori et al. 2003) . As outlined by Farkas et al. (2007) the rat 2VO model is useful to investigate the long-term effects of chronic cerebral hypoperfusion (Farkas et al. 2007 ) since hypoperfusion is global although mild, and represents a model of cerebrovascular stenosis in aging humans. Furthermore, the damage to the nervous tissue, although chronic, is less dramatic than in focal ischemic models (Farkas et al. 2007 ). In a recent paper we studied the quantitative and qualitative changes induced by 2VO on neurons, astrocytes, microglia, in hippocampal CA1 (Lana et al. 2014 ). Here we studied the effect of 2VO on hippocampal area CA3 and the comparison between the results obtained in CA1 and CA3 will be useful to understand the different reactivity of the two areas during hypoperfusion, and more specifically to understand if and why CA3 pyramidal neurons show better adaptation to an ischemic insult and to degeneration in comparison to CA1 pyramidal neurons, as reported by Kirino (2000) . In our study, dipyridamole was tested in the 2VO model to evaluate its protective role against the physiopathological mechanisms that the ischemic insult exerts in the CA3 region of the hippocampus.
Brain chronic hypoperfusion, caused by partial carotid occlusion during aging, represents a chronic, dynamic process that causes multiple progressive alterations, and eventually leads to neurodegeneration (Ozacmak et al. 2007; Farkas et al. 2007 ) and vascular dementia (Chmayssani et al. 2007 ). The CA1 region of the hippocampus results particularly vulnerable to decreased blood flow and glucose supply caused by 2VO occlusion, that cause failure of neuronal signaling, and impairments in hippocampally-based forms of memory (De Jong et al. 1999; Liu et al. 2005; Farkas et al. 2006; Melani et al. 2010; Lana et al. 2013) . It is well known that CA3 and CA1 hippocampal areas, although well interconnected, respond differently to ischemic/hypoxic insults (Kirino 2000) . As demonstrated in animal models (Schmidt-Kastner and Freund 1991), CA1 neurons of patients with cerebral hypoxia are the most vulnerable in the brain (Zola-Morgan et al. 1986; Petito et al. 1987) . At early stages after an ischemic insult the pyramidal neurons from CA1 and CA3 are exposed to similar triggering events such as the increase of extracellular glutamate (Mitani et al. 1992) . Energy deprivation reduces intracellular ATP modifying the ionic gradients and inverting glutamate transport both in pyramidal CA1 (Rossi et al. 2000) and CA3 neurons (Jabaudon et al. 2000) . At later times, NMDAmediated responses increase in CA1 pyramidal neurons, which become more sensitive, while are transiently depressed in CA3 pyramidal neurons, that become more resistant. It has also been demonstrated that the balance kinase/phosphatase is different between CA1 and CA3. In CA1 the balance kinase/phosphatase is in favor of kinase activity, while in CA3 it is in favor of phosphatase activity (Gee et al. 2006) . Nevertheless, the question that remains to be answered to is how and why these two contiguous, interconnected regions of the hippocampus respond differently to an ischemic event.
Here we exploited the 2VO hypoperfusion paradigm to verify whether and how the interaction between glia and neurons in CA3 may change after hypoperfusion. Immunohistochemistry and confocal microscopy analysis revealed the presence of significantly more numerous "ectopic" pyramidal neurons in the CA3 Str. Radiatum of 2VO rats, localized both in SL and SR layers. The cells we defined as ectopic neurons had a pyramidal shape, typical of pyramidal neurons and were located both in SL and in SR of CA3. Most ectopic neurons were not calretinin-positive, indicating that they are not interneurons, but possibly pyramidal neurons. It has been demonstrated that caspases break the cell cytoskeleton during the first stages of apoptosis in order for the apoptotic cell to be detached from the surrounding cells (Böhm 2003) . This mechanism may explain how cells migrate from the SP to the contiguous SL or SR where phagocytosis may occur. Indeed, since the SL subregion is paradigmatically defined as "a-neuronal" (Amaral and Lavenex 2007) , the ectopic neurons are likely migrating from CA3 SP. We also found no difference in the number of calretinin-positive interneurons in SL or SR of the three experimental groups, a finding indicating that in this model of mild ischemia CA3 interneurons were not affected, contrary to what has been found in 4 vessel occlusion, a model of more robust ischemic damage (Freund and Maglóczky 1993; Hsu and Buzsáki 1993) .
We demonstrated higher expression of the proinflammatory cytokine TNF-α in astrocytes and dendrites localized in SR of 2VO-vehicle rats. It has been previously demonstrated that astrocytes have the capacity to secrete TNF-α (Chung and Benveniste 1990) and that TNF-α colocalized with neurofilaments in the cerebral cortex (Liu et al. 1994) in response to a variety of stimuli such as ischemia. Dipyridamole, blocking the increased expression of the cytokine TNF-α in astrocytes, may decrease the proinflammatory milieu associated with the ischemic insult.
Using immunostaining for CytC, a late marker of apoptosis, we demonstrated that in CA3 SP and SL of 2VO-vehicle rats many neurons were apoptotic, significantly more numerous in SP of hypoperfused rats. Since it has been demonstrated that active and controlled cell death serves a homeostatic function in regulating the size of cell populations under both normal and pathophysiologic conditions (Becker and Bonni 2004; Kerr et al. 1972 ), a certain percentage of neuronal population undergoing apoptosis even in sham rats is to be expected. Nevertheless, our data demonstrating increased number of cells undergoing apoptosis in SP of 2VO-vehicle rats is in accordance with the current idea that apoptosis has importance in acute and chronic neurological diseases, as reported by Becker and Bonni (2004) . We also demonstrated the presence of a significantly higher number of neuronal debris, possibly deriving from apoptotic neurons, both in SL and SR of 2VO-vehicle rats, but not in SL and SR of 2VO-dypiridamole treated rats. This latter finding may explain the protective effect of dypiridamole, as explained in more details below.
Despite the increase of apoptotic neurons, of ectopic neurons and of neuronal debris in hippocampal SL and SR of 2VO-vehicle rats, we did not find significant decrease of CA3 pyramidal neurons in comparison to sham rats, as we had also found in CA1 (Lana et al. 2014 ). This effect could depend upon increased neurogenesis during the restitution phase of brain chronic ischemia, as shown in vivo (Dirnagl 2012; Farkas et al. 2007 ) and in vitro (Maraula et al. 2013 ) in models of chronic ischemia. Newborn neurons may then migrate from the subgranular zone (SGZ) of the Dentate Gyrus (DG) to integrate the apoptotic neurons in the CA3 pyramidal layer.
During chronic cerebral hypoperfusion astrogliosis is generally considered a late-emerging event (Farkas et al. 2007; Farkas et al. 2004 Farkas et al. , 2006 Pappas et al. 1996; Schmidt-Kastner et al. 2005) in the hippocampus. Consistently, we found significant increase of astrocytes in SP and SR of 2VO-vehicle rats and in SP, SL and SR of 2VO-dypiridamole treated rats. The length of astrocyte branches were not different among groups and regions investigated, indicating that the astrocytes were not hypertrophic or hyperactivated. We hypothesize that the increased number of astrocytes might be the consequence of higher demand of oxygen and nutrients by neurons that are in a hypoxic/hypoglycemic milieu given by the hypoperfusion state. The reduced trophic support to CA3 neurons could be balanced by increased number of astrocytes. This phenomenon, contrary to that observed in CA1 in the same model of chronic cerebral hypoperfusion (Lana et al. 2014) , can be considered a protective effect of astrocytes towards neurons. The idea that an increased number of astrocytes is always a negative phenomenon is rapidly changing, thanks to new data and to new concepts that suggest a more complex and more variegated role of astrocytes in physiological mechanisms and in different neuropathological disorders (Sofroniew 2009; Verkhratsky et al. 2013; Burda and Sofroniew 2014; Hamby and Sofroniew 2010) . It is becoming more and more evident that dysfunctions in the process of astrogliosis contribute to or are the primary cause of damaging mechanisms in the central nervous system, both through loss of normal functions and through increase of damaging effects (Sofroniew 2009 ). As reported by Sofroniew (Sofroniew 2009; Sofroniew and Vinters 2010) , and demonstrated in other papers from our laboratory (Lana et al. 2014 (Lana et al. , 2016 astrogliosis is not a single uniform process, nor always synonymous with scar formation. In moderate reactive astrogliosis, such as the one we found in CA3 SL and SR, astrocyte proliferation is scarce, and astrocytes do not form scars but occupy non-overlapping domains (Bushong et al. 2002) . Astrocytes infiltrate their branches inside the body of ectopic pyramidal neurons to trigger or help their disgregation, as previously found (Cerbai et al. 2012; Re et al. 2014; Lana et al. 2014 Lana et al. , 2016 . Indeed, with the triple immunostaining of neurons, astrocytes and microglia we demonstrated that in in SL and SR of the three experimental groups many ectopic neurons were surrounded by astrocyte branches and by microglia forming the socalled triads. Triads were significantly more numerous in the SR of 2VO-vehicle rats than in the two other groups. Dypiridamole reduced this effect, although not completely. The phenomenon of neuron infiltration, and fragmentation by astrocytes branches, first demonstrated in our laboratory (Cerbai et al. 2012) , was later confirmed by Re and coworkers in a model of ALS (Re et al. 2014) and in other papers from our group (Lana et al. 2014 (Lana et al. , 2016 . As we demonstrated, astrocyte branches intermingled and penetrated the neuronal cytoplasm, fragmenting the neuronal cell body to give rise to cellular debris. The fragmentation of ectopic neurons may be the consequence of the apoptotic process which these neurons were undertaking because of the ischemic state of the tissue after 2VO. Fragmentation of apoptotic neurons may be triggered or accelerated by astrocyte branches infiltrating the neuronal cell body, forming smaller debris ready for phagocytosis by microglia, as demonstrated in other models of neurodegeneration (Cerbai et al. 2012; Huizinga et al. 2012; Polazzi and Monti 2010) . Thus, we hypothesize that it may represent a mechanism common to many neurodegenerative processes.
We found an increase of IBA1 positive microglia in SL and SR of 2VO-vehicle and 2VO-dypiridamole treated rats, an indication that the low grade of local inflammation could recruit microglia in these regions, while in SP of 2VO-dipyridamole rats IBA1 positive microglia decreased. Microglia recruitment and activation has long been considered a negative mechanism that leads to accumulation of neurotoxic phagocytes, but more recently it is considered a reversible multistep process which leads to neuroprotective effects (Hanisch and Kettenmann 2007; Kettenmann et al. 2013; Ransohoff and Perry 2009) . We found that many microglial cells cooperated with astrocytes forming triads to remove, through phagocytosis, degenerating, apoptotic neurons, both in SR of 2VO-vehicle and 2VO-dypiridamole treated rats. In SL and SR of 2VO-dypiridamole treated rats we found the presence of a significantly lower number of neuronal debris. Several authors have indicated that microglial activation following neuronal injury represents mainly a protective mechanism that limits further neurodegeneration (Minghetti and Levi 1998; Streit et al. 1999; Polazzi and Contestabile 2002) . Indeed, it has been shown that phagocytosis of apoptotic cells by microglia decreases the production of pro-inflammatory cytokines, such as TNF-α and IL-12, without affecting the secretion of anti-inflammatory and potentially neuroprotective molecules, such as IL-10 and TGF-ßl (Magnus et al. 2001) . It has also been demonstrated that microglia releases molecules able to rescue neurons from apoptotic death and, in turn, diffusible signals from apoptotic neurons enhance the neuroprotective properties of microglia (Polazzi et al. 2001 ). This effect may also be responsible for the recently described phenomenon of phagoptosis (Brown and Neher 2012; Zhang and Baehrecke 2015) through which microglia is able to phagocyte whole neurons damaged by the ischemic insult that do not show any sign of neurodegeneration (see Fig. 3H1-H3 ). The heterogeneous distribution of microglia, which is more densely present in SL in comparison to SP, may thus be functional for the protective role that microglia may have in these conditions (Morsch et al. 2015) , and particularly in this CA3 subregion where we also demonstrated a higher number of ectopic neurons and triads. It was also found that CA1 pyramidal cell death, 1 day after OGD, was significantly increased in microglia-depleted organotypic cultures, again suggesting a neuroprotective role of the normal content of microglia (Montero et al. 2009 ). Since it is well known that the CA3 area of the hippocampus is more resistant than the CA1 to ischemic insults, the increase of microglia cells that occurs in concert with the removal of dead cells (Nathan and Ding 2010) may have both anti-inflammatory effects and consequently neuroprotective properties (Liesz et al. 2009 ). Indeed, the microglia increase in CA3 and decrease in CA1 (Lana et al. 2014 ) may explain the higher sensitivity of CA1 pyramidal cells to an ischemic insult. Our results may be interpreted as follows: the increase of total microglia in CA3 SL and SR of 2VO-vehicle rats, during the restitution phase of brain chronic hypoperfusion, may depend on the release of antiinflammatory cytokines that boosts an anti-inflammatory milieu (Spite and Serhan 2010) . Though very sparse OX-positive, activated, microglia cells were found in SP, SL and SR of the three experimental groups, many IBA1-positive, reactive microglia cells (Beynon and Walker 2012 ) phagocytosed ectopic pyramidal neurons or neuronal debris in CA3 SR of 2VO-vehicle rats. The high motility of microglia that effectively monitor the status of the local surroundings may explain the decrease of microglia in CA3 SP and the increase in CA3 SL and SR where it endocytoses small cellular debris derived from apoptotic cells (Neumann et al. 2009 ). Therefore, post-ischemic production of cytokines and recruitment of microglia to the damaged tissue (Farkas et al. 2002) can facilitate tissue repair by increasing phagocytosis or phagoptosis, promoting the resolution of inflammation and exerting direct cytoprotective effects on surviving cells in the ischemic area. It would be of interest to investigate the modification of the number of microglia in the acute phase of brain chronic hypoperfusion, taking hippocampal sections at earlier times after 2VO-vehicle and make a comparison between CA3 and CA1 areas.
As reported (Iadecola and Anrather 2011) , the post-ischemic insult is a self-limiting process subsiding during the so-called restitution phase (Dirnagl 2012; Farkas et al. 2007 ) and preparing the terrain for the structural and functional reorganization of the injured brain. The restitution phase is thought to be orchestrated by the interplay of numerous cells, processes and mediators (Spite and Serhan 2010) , including development of an anti-inflammatory milieu, removal of dying/ apoptotic cells, and neurogenesis, (Nathan and Ding 2010; Spite and Serhan 2010) . We used hippocampal sections from animals 90 days after 2VO, a sufficient time for the tissue to undergo the restitution phase after brain chronic ischemia (Dirnagl 2012; Farkas et al. 2007 ). Nevertheless, we found that TNF-α levels were still higher both in astrocytes and dendrites in CA3 of 2VO-vehicle rats. Dipyridamole reverted, although partially, this effect.
Dipyridamole, introduced in therapy in 1959 as an antianginal drug (Picano 1989) , is a potent inhibitor of platelet activation (Heptinstall et al. 1986 ), reduces thrombi formation in vivo (Elkeles et al. 1968) , and has beneficial effects in therapy for secondary stroke prevention (Halkes et al. 2006 ). Experimentally we have demonstrated that dipyridamole significantly restores hippocampally based spatial memory (Melani et al. 2010) and has a protective effect on hippocampal CA1pyramidal neurons (Lana et al. 2014 ) 90 days after 2VO. The increases of extracellular adenosine (Figueredo et al. 1999) , together with increased VEGF production (Ernens et al. 2010) , and the potentiation of the NO system (Aktas et al. 2003; Venkatesh et al. 2010) help explaining the protecting effect of dipyridamole in this rat model of hypoperfusion. Dipyridamole has a positive effect on blood flow and angiogenesis through the nitrite/NO endocrine system (Venkatesh et al. 2010) , increases NO levels and decreases superoxide formation both in ischemic and non-ischemic animals (Pattillo et al. 2011) , and has pleiotropic pharmacological effects, such as antioxidant and antiinflammatory proprieties (Blake 2004; Eisert 2002; Hsieh et al. 2010; Riksen et al. 2005) . Dipyridamole decreases the production of proinflammatory cytokines (Al Bahrani et al. 2007) , chemokines (Weyrich et al. 2005) , inhibits matrix metalloprotease-9 (Weyrich et al. 2005 ), COX-2 activity (Chen et al. 2006) , and the neutrophil adhesion to endothelium (Chello et al. 1999) .
We demonstrated that apoptosis in CA3 SP decreased significantly in 2VO-dipyridamole rats in comparison to 2VO-vehicle rats. An interesting result was the decrease of neuronal death associated with reduced formation of the triads in CA3 SR in 2VO-dipyridamole rats in comparison with 2VO-vehicle rats. These data clearly show the beneficial effect of dipyridamole against the physiopathological mechanisms of the ischemic insult. The conspicuous number of ectopic neurons and the increase of microglial cells in 2VO-vehicle and 2VO-dipyridamole rats in comparison to sham rats might be due not only to phagocytosis by microglia, but also to the newly defined mechanism of neuronal death called phagoptosis (Zhang and Baehrecke 2015) . In this mechanism microglial cells engulf and digest whole neurons that appear damaged but still not fragmented. According to our data we show that microglial cells engulf some ectopic neurons, particularly in SL of 2VO-vehicle and 2VO-dipyridamole rats.
We hypothesize that the administration of dipyridamole during the acute phase of brain chronic hypoperfusion is responsible for the smart opposition towards the progression of the pathophysiological mechanisms of the ischemic insult. This hypothesis is sustained by the reversion of many of the effects observed in 2VO-vehicle rats by dipyridamole, such as the further increase of microglia in CA3 SL and SR that mirrors the decrease of neuronal debris in the same regions. We had previously demonstrated that dypiridamole restores the number of microglia in CA1 (Lana et al. 2014) . Further experiments are needed to fully understand the mechanisms of dipyridamole in rescuing the CA3 hippocampal region from the damages induced by chronic hypoperfusion.
Comparison between CA1 and CA3
The comparison between the results obtained in CA1 and CA3, shown in Table 1 , is useful to understand the different reactivity of the two areas after the ischemic insult, more specifically to understand why CA3 shows better adaptation to an ischemic insult and to degeneration in comparison to CA1. In CA1 and CA3 areas there is no significant difference in the number of pyramidal neurons between ischemic rats and sham rats. However, we found a significant increase of programmed cell death in SP of both CA1 and CA3 regions. The increase of apoptotic neurons was comparable in the two regions. However, the effect of dipyridamole was different, since the drug blocked the increase of apoptotic neurons in CA3 (−41%), but not in CA1. This is a first important difference found between the two areas; indeed, it appears that CA3 −14% +18%** −0.1% Microglia in SR 201 ± 12 166 ± 9 204 ± 9 265 ± 14 301 ± 9 322 ± 8 −17%* +23% # +14%* + 7 % Triads in SR 3,1 ± 0.3 8,0 ± 0,7 3,5 ± 0,7 3 ± 1,0 13 ± 0,5 7 ± 1,4 +158%*** −56% responds better to the neuroprotective effects of the drug. We then analyzed the ectopic pyramidal neurons. We hypothesize that the change of location of pyramidal neurons from their competence layer to the underlying SL or SR, is a scavenging, protective mechanism for the damaged neurons to be phagocytosed by microglial cells. The migration of neurons from the SP can also prevent the diffusion of damaging molecules to surrounding vital neurons. Indeed, we found a significant increase of ectopic pyramidal neurons both in CA1 and in CA3 areas. We can see from the Table that in CA3 the density of ectopic pyramidal neurons was significantly higher (+103%) in comparison to CA1 (+49% increase). Therefore, it seems that in CA3 the scavenging mechanism of pyramidal neurons under degeneration is more active. This is another important difference between the two areas that may explain the higher resistance of the hippocampal CA3 area to ischemic degeneration.
We found significantly higher density of neuronal debris both in CA1 and CA3 of ischemic rats, and this increment was more remarkable in CA3 (+ 82% in CA3 and + 37% in CA1). Besides, in 2VO-dipyridamole treated rats, we found that the drug reduced the increase of neuronal debris in both areas.
Astrocytes did not significantly vary in CA1 of the three experimental groups, while in CA3 there was a significant increase of astrocytes in ischemic rats and in rats treated with dipyridamole. As mentioned, this phenomenon can be the consequence of an increased trophic request of the tissue and may represent a sign of a better response of CA3 to the ischemic insult in comparison to CA1.
Another fundamental difference between the two areas was found in microglial density: in CA3 microglia was significantly increased in 2VO-vehicle rats and in 2VO-dipyridamole treated rats. This event was not present in CA1, where, on the contrary, microglial cells decreased in 2VO-vehicle rats while dipyridamole restored microglia density. As mentioned earlier, since in recent scientific literature microglia activation is seen as a protective mechanism (Hanisch and Kettenmann 2007; Kettenmann et al. 2013; Ransohoff and Perry 2009) , we can assume that the increase of microglial cells found in CA3 is a further sign of better responsiveness of this area to an ischemic insult, in comparison to CA1.
Finally, in both CA1 and CA3, the neuron-astrocytes-microglia triads were significantly more numerous in 2VO-vehicle rats, but this phenomenon was more marked in CA3 (+ 333%) than in CA1 (+ 158%). In 2VO-dipyridamole treated rats we found a reduction of triads in both areas (−56% in CA1 and −46% in CA3), thus confirming the neuroprotective effect of dipyridamole.
Taken together, our results demonstrate the presence of neuronal damage and alteration in the interplay between neurons and glia in CA3 of 2VO-vehicle rats. The effect of dipyridamole to revert or slow the progression of the pathophysiological mechanisms of brain chronic hypoperfusion seems to depend in this region upon its role as an antiinflammatory drug increasing the phagocytic/phagoptotic activity of microglia. Astrocytes and microglial cells actions might contribute to the neuronal damage in a pathological condition but also represent a protective mechanism to control the inflammatory process and the ensuing diffusion of the cellular damage in the neighbouring tissues.
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